PREPARATION OF OPTIONALLY SUBSTITUTED DIHYDROISOQUINOLINES
Preparation of optionally substituted dihydroisoquinolines The present invention relates to a process for the preparation of optionally substituted dihydroi- soquinolines of the formula I
-
Page/Page column 28
(2019/08/14)
HALOGENATION OF PYRIDINE DERIVATIVES
The present invention relates to a process for the preparation of pyridine derivatives of the formula (I) comprising two steps, namely, a selective chlorination followed by a selective fluorination.
-
Page/Page column 21; 22
(2019/08/12)
PREPARATION OF OPTIONALLY SUBSTITUTED 5-SUBSTITUTED PYRIDINE
The present invention relates to a process for the preparation of optionally substituted 5-substituted pyridine of the formula I.
-
Page/Page column 25
(2019/08/12)
BROMINATION OF PYRIDINE DERIVATIVES
The present invention relates to a process for the preparation pyridine derivatives of the formula (I).
-
Page/Page column 16
(2019/08/12)
BETA-LACTAMASE INHIBITORS
Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.
-
Paragraph 0520
(2014/07/22)
The Bromination of Lutidines
-
Dunn, Allan D.,Guillermic, Sandrine
p. 59 - 60
(2007/10/02)
SUBSTITUTED ISOCYTOSINES HAVING HISTAMINE H2-ANTAGONIST ACTIVITY
The compounds are substituted isocytosines which are histamine H 2-antagonists. Two specific compounds of the present inventon are 2-2-(5-methyl-4-imidazolylmethylthio)ethylamino!-5-(3-pyridylmethyl)-4-pyrimi done and 2-2-(3-bromo-2-pyridylmethylthio)ethylamino!-5-(4-pyridylmethyl)-4-pyrimidone .
-
(2008/06/13)
More Articles about upstream products of 27063-90-7